Skip to main content
. 2021 Jul 29;11:706652. doi: 10.3389/fonc.2021.706652

Figure 5.

Figure 5

The subgroup analysis of PFS in patients with high TMB compared to those with low TMB. PFS, progression-free survival; TMB, tumor mutational burden.